CNSP - CNS Pharmaceuticals, Inc.
2.94
-0.060 -2.041%
Share volume: 22,735
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.00
-0.06
-0.02%
Summary score
22%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-46601.94%
Return on assets
-43.21%
Return on sales
0%
Return on invested capital
1063.99%
Total debt ratio
87.81%
Debt ratio change over timeo
0%
Current Ratio
6.93%
Quick Ratio
0%
Cash Position Ratio
5.47%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-60.31%
Return on assets
-53.78%
Return on sales
0%
Return on invested capital
2253.1%
Total debt ratio
9.2%
Debt ratio change over timeo
0%
Current Ratio
15.15%
Quick Ratio
0%
Cash Position Ratio
11.97%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-81.27%
Return on assets
-67.37%
Return on sales
0%
Return on invested capital
4820.15%
Total debt ratio
17.11%
Debt ratio change over time
0%
Current Ratio
4.93%
Quick Ratio
0%
Cash Position Ratio
2.56%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CNSP | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -46601.94% | 18.71% | 4.67% | -3.65% |
| Return on assets | -43.21% | 3.4% | 3.32% | 3.5% |
| Return on sales | 0% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 1063.99% | 5.38% | 4.17% | 4.99% |
| Profitability | 25% | 69% | 51% | 50% |
| Total debt ratio | 87.81% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 22% | 20% | 20% | 50% |
| Current Ratio | 15.15% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 11.97% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 26% | 32% | 33% |
| Short-term ratios | CNSP | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -60.31% | 41.05% | 6.87% | -16.17% |
| Return on assets | -53.78% | 3.67% | 3.13% | 2.71% |
| Return on sales | 0% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 2253.1% | 9.43% | 5.58% | 6.54% |
| Profitability | 25% | 72% | 46% | 44% |
| Total debt ratio | 9.2% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 2% | 23% | 40% | 25% |
| Current Ratio | 15.15% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 11.97% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 15% | 18% | 31% |